Tumor Ablation Market

Tumor Ablation Market by Technology (Radiofrequency, Microwave, Cryoablation, IRE, Ultrasound, Laser), Mode of Treatment (Surgical, Laparoscopic, Percutaneous), Application (Liver, Lung, Kidney, Bone Metastasis, Prostate, Breast) - Global Forecast 2021

Report Code: MD 3271 Oct, 2016, by marketsandmarkets.com

[183 Pages Report] The global tumor ablation market is estimated to grow at a CAGR of 12.5% to reach USD 580.1 Million by 2021. Technological advancements in the field of tumor ablation coupled with increased procedural safety profile, rising market demand of minimal invasive tumor ablation techniques, increasing prevalence of cancer across the globe, as well as growing number of public-private initiatives & funding to support ongoing research activities related to tumor ablation are propelling the growth of the market. However, factors such as unfavorable regulatory policies and cost containment measures adopted by various governments are restraining the optimal market growth.

Tumor Ablation Market

This market has evolved significantly in the last two decades. This can primarily be attributed to the emergence of various technologically advanced devices, such as multi-polar and bipolar electrodes, temperature-controlled and fluid-cooled ablation catheters, and imaging and contact force measuring sensors. Most of the leading manufacturers and new market entrants are investing heavily in R&D activities to develop novel tumor ablation products and to expand the clinical application profile of their existing tumor ablation products. In line with this strategy, from 2013 to 2016, the global market witnessed several initiatives by key players (Covidien, Plc, Medtronic, Inc., NeuWave Medical, Inc., and SonaCare Medical, LLC, among others) to strengthen their R&D capabilities.

In the published report, the global tumor ablation market is segmented on the basis of technology, mode of treatment, applications, and regions. On the basis of technology, the radiofrequency ablation accounted for the largest share in the global market, in 2016, which can primarily be attributed to its ease of treatment (as compared to open surgical procedure), its proven clinical efficacy and safety profile, and ongoing developments & commercialization of technologically advanced radiofrequency tumor ablation systems.

Geographically, the global market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, Geographically, North America is estimated to command the largest share of the global market in 2016, followed by Europe. The large market share of the North American region can be attributed to high prevalence and incidence of major types of cancer (such as liver, lung, kidney, and bone metastasis) in the region, rising inclination of patients towards minimally invasive procedures for cancer treatment, and increasing government funding for cancer research. However, unfavorable regulatory scenario and cost containment measures adopted by government are negatively affecting the growth of the market in this region.

As of 2016, Medtronic plc (Ireland) held the leadership position in the global tumor ablation market. Over the past three years, the company has adopted new product launches, product enhancements, and geographic expansion as its key business strategies to ensure its dominance in this market. Angiodynamics, Inc. (U.S.), Boston Scientific Corporation (U.S.), Galil Medical, Inc. (U.S.), EDAP TMS S.A. (France), Healthtronics, Inc. (U.S.), Medtronic, Plc (U.S.), Mermaid Medical, Inc. (Denmark), Mesonix, Inc. (U.S.), Neuwave Medical, Inc. (U.S.) and Sonacare Medical, LLC (U.S.) are some of the other key players operating in the market.

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report

This research report categorizes the tumor ablation market into the following segments:

Global Market, by Technology

  • Radiofrequency (RF) Ablation
  • Microwave Ablation
  • Cryoablation
  • Other Technologies

Global Market, by Mode of Treatment

  • Percutaneous Ablation
  • Laparoscopic Ablation
  • Surgical Ablation

Global Market, by Mode of Treatment

  • Liver Cancer
  • Lung Cancer
  • Kidney Cancer
  • Bone Metastasis
  • Others

Global Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Italy
    • Germany
    • France
    • U.K.
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • Rest of the World (RoW)

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for tumor ablation market report:

Product Analysis

  • Product Matrix which gives a detailed comparison of the product portfolios of each company

Geographical Analysis

  • Further breakdown of the RoAPAC market into the Australia, Rest of Pacific, and Rest of Asia
  • Further breakdown of the RoW market into the Middle East, Latin America, and Africa

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

The tumor ablation market is projected to grow from an estimated USD 321.9 Million in 2016 to USD 580.1 million by 2021 at a CAGR of 12.5%.

Growth in the tumor ablation market is mainly driven by the significant geriatric population and rising cancer patient population across the globe, and ongoing technological advancements in the field of tumor ablation products.

By technology, the microwave ablation segment is expected to grow at the highest rate during the forecast period in the tumor ablation market

The microwave tumor ablation technology is the fastest-growing ablation technology segment that is currently being used to treat various cancers (such as liver, lung, and kidney).

Growth in the in microwave ablation segment is attributed to increasing private funding for novel product development of microwave ablation, its significant efficiency over other ablation technologies, and growing adoption of the microwave tumor ablation procedure among healthcare professionals to treat various cancers.

By mode of treatment, surgical ablation segment is expected to be the largest contributor to the tumor ablation market in 2016

Surgical tumor ablation is a minimally invasive surgical procedure in which ablation probes/catheters are used to deliver energy directly to the cancer site for treatment. This does not involve surgical removal of affected tissues or tumors. Surgical ablation is performed on patients ineligible for the surgical removal of tumor/cancer tissue.

The stable market growth witnessed by the surgical tumor ablation segment is mainly due to the large number of minimally invasive surgical procedures performed in mature markets (such as the U.S., the U.K., Italy, Germany, and Japan) to treat various cancers, growing market awareness about the benefits of surgical ablation in emerging markets (coupled with rapid modernization of regional healthcare infrastructure), and large proportion of cancer patients ineligible for surgical cancer treatment (paired with growing patient base for key cancers such as liver, kidney, lung, and prostate).

Tumor Ablation Market

North America is expected to account for the largest share of the market during the forecast period

North America is one of the major revenue-generating regions in the global tumor ablation market. The large share of this regional segment can mainly be attributed to early introduction of tumor ablation technologies in the region, continuous technological advancements occurring in the field of tumor ablation catheters, and growing private-public investments to develop innovative tumor ablation technologies (coupled with the growing public awareness related to the benefits of tumor ablation).

Key Market Players

The tumor ablation market is a diverse and highly competitive market with a large number of players. Some of the prominent players in the tumor ablation are Medtronic, Plc (U.S.), AngioDynamics, Inc. (U.S.), HealthTronics, Inc. (U.S.), Galil Medical, Inc. (U.S.) and Boston Scientific Corporation (U.S.).

Medtronic is one of the key global manufacturers of tumor ablation products; with strong brand positioning across developed markets (such as the U.S., Japan, and Germany). The company focuses on both organic (product development and new product launches) and inorganic (strategic acquisitions and collaborations) growth strategies to further strengthen its footprint in the global tumor ablation market. The acquisition of Covidien Plc (Ireland) for USD 42.9 billion (January 2015) was a key development for Medtronic. This acquisition helped Medtronic to enter the tumor ablation businesses and expand its geographic presence. Other significant developments include: securing FDA pre-marketing approval for the Emprint ablation System (July 2014) and launch of the HALO90 ULTRA Ablation Catheter (July 2014)

AngioDynamics, Inc. is among the prominent market players in global tumor ablation industry. The company offers several innovative tumor ablation products (such as NanoKnife system, StarBurst RFA system, and UniBlate RFA electrodes); which helped the company to position itself among leading players in this segment. The company pursued strategic acquisitions and expansion of its existing product portfolio as its key growth strategy. During 2013-2016, the company undertook several key acquisitions that helped AngioDynamics to strengthen its market positioning and geographic presence; such as acquisition of Microsulis Medical Ltd. (U.S.) and Navilyst Medical Inc. (U.S.). The company is particularly focused on technological development and commercialization of its NanoKnife ablation system; pertaining to product’s excellent clinical results obtained during cancer treatment studies.

Recent developments:

  • In October 2015, AngioDynamics, Inc. launched its NanoKnife Ablation system in South Korea after receiving regulatory approval by Ministry of Food and Drug Safety (South Korea). This helped AngioDynamics expand its product portfolio for tumor ablation market
  • In July 2016, Boston Scientific Corporation acquired the Cosman Medical Inc. (U.S.) at an undisclosed value. Cosman Medical is a leading manufacturer of radiofrequency ablation devices. This acquisition helped Boston Scientific to strengthen its technological capabilities and to expand its product sales and distribution network in the global tumor ablation market
  • In May  2016, Galil Medical Inc. was acquired by the  BTG  plc group (a part of BTG International Ltd, U.K.); for a value of USD 110.0 million. BTG International is prominent manufacturer of cryoablation products and possesses strong product distribution network across Europe. The acquisition helped Galil Medical to strengthen its technological capabilities and to expand its distribution network in global tumor ablation market
  • In april 2016, Medtronic plc launched Barrx 360 Express radiofrequency ablation (RFA) balloon catheter; for the treatment of Barrett's esophagus. It helped the company to provide technologically advanced product to its customers in tumor ablation market

Key questions addressed in the report:

  • What are the growth opportunities related to tumor ablation across major regions in the future?
  • Emerging countries have immense opportunities for the growth and adoption of tumor ablation products. Will this scenario continue in the next five years?
  • Where will all the advancements in products offered by various companies take the industry in the mid- to long-term?
  • What are the new trends and advancements in the tumor ablation market?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Geographic Scope
           1.3.3 Years Considered for the Study
    1.4 Limitations
    1.5 Market Stakeholders

2 Research Methodology
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Key Industry Insights
                    2.1.2.3 Breakdown of Primaries
    2.2 Market Size Estimation
           2.2.1 Top-Down Approach
           2.2.2 Bottom-Up Approach
    2.3 Market Breakdown and Data Triangulation
    2.4 Research Assumptions

3 Executive Summary
    3.1 Introduction
    3.2 History, Evolution, and Current Scenario
    3.3 Future Outlook
    3.4 Conclusion

4 Premium Insights

5 Market Overview
    5.1 Introduction
    5.2 Market Segmentation
           5.2.1 Market, By Technology
           5.2.2 Market, By Mode of Treatment
           5.3.3 Market, By Application
    5.3 Market Evolution
    5.4 Market Dynamics 
           5.4.1 Key Market Drivers
                    5.4.1.1 Growing Geriatric Population Across the World
                    5.4.1.2 Increasing Population Base for Cancer Patients
                    5.4.1.3 Technological Advancements in Ablation Devices
                    5.4.1.4 Sprouting Number of Hospitals, Surgical, and Ablation Centers
           5.4.2 Key Market Restraints
                    5.4.2.1 Cost Containment Measures Taken By Various Governments
                    5.4.2.2 Ongoing Healthcare Reforms in the U.S.
           5.4.3 Key Market Opportunities
                    5.4.3.1 Growth Potential Offered By Emerging Markets
                    5.4.3.2 Growing Awareness About Ablation Procedures Over Conventional Therapeutic and Surgical Procedures
           5.4.4 Key Market Challenges
                    5.4.4.1 Stringent Regulatory Guidelines Leading to Significant Increase in Gestation Period of Product Launches

6 Industry Insights
    6.1 Introduction
    6.2 Value Chain Analysis
    6.3 Industry Trends
           6.3.1 Growing Adoption Rate of Radiofrequency-Based Tumor Ablation Procedures
           6.3.2 Microwave Technology to Be the Fastest Growing Segment in Overall Tumor Ablation Businesses
    6.4 Porter's Five Forces Analysis
           6.4.1 Threat From New Entrants
           6.4.2 Threat From Substitutes
           6.4.3 Bargaining Power of Suppliers
           6.4.4 Bargaining Power of Buyers
           6.4.5 Intensity of Competitive Rivalry

7 Tumor Ablation Market, By Technology
    7.1 Introduction
    7.2 Radiofrequency (RF) Ablation 
    7.3 Microwave Ablation
    7.4 Cryoablation 
    7.5 Other Technologies*

8 Tumor Ablation Market, By Mode of Treatment
    8.1 Introduction
    8.2 Surgical Ablation
    8.3 Laparoscopic Ablation 
    8.4 Percutaneous Ablation

9 Tumor Ablation Market, By Application
    9.1 Introduction
    9.2 Liver Cancer
    9.3 Lung Cancer
    9.4 Kidney Cancer
    9.5 Bone Metastasis
    9.6 Others**

10 Tumor Ablation Market, By Region
     10.1 Introduction
     10.2 North America
             10.2.1 U.S.
             10.2.2 Canada
     10.3 Europe
             10.3.1 Italy
             10.3.2 Germany
             10.3.3 France
             10.3.4 U.K.
             10.3.5 Spain
             10.3.6 Rest of Europe
     10.4 Asia-Pacific
             10.4.1 Japan
             10.4.2 China
             10.4.3 India
             10.4.4 Rest of Asia-Pacific
     10.5 Rest of the World (RoW)

11 Competitive Landscape
     11.1 Introduction
     11.2 Market Share Analysis, By Key Players
     11.3 Competitive Scenario
     11.4 Recent Developments
             11.4.1 New Products Launches and Product Enhancements
             11.4.2 Agreements, Partnerships, and Agreements
             11.4.3 Mergers and Acquisitions
             11.4.4 Geographic Expansions
             11.4.5 Other Developments

12 Compny Profiles
     12.1 Introduction
             12.1.1 Geographic Benchmarking
             12.1.2 Strategic Benchmarking
     12.2 Medtronic, PLC.
             12.2.1 Company Overview
             12.2.2 MnM Overview
             12.2.3 Medtronic, PLC: Company Snapshot
             12.2.4 Product Portfolio
             12.2.5 Recent Developments (2014-2015)
     12.3 Angiodynamics, Inc.
             12.3.1 Company Overview
             12.3.2 MnM Overview
             12.3.3 Angiodynamics, Inc.: Company Snapshot
             12.3.4 Product Portfolio
             12.3.5 Recent Developments (2014-2015)
     12.4 Healthtronics, Inc.
             12.4.1 Company Overview
             12.4.2 MnM Overview
             12.4.3 Boston Scientific Corporation: Company Snapshot
             12.4.4 Product Portfolio
             12.4.5 Recent Developments (2014-2015)
     12.5 Galil Medical, Inc.
             12.5.1 Company Overview
             12.5.2 MnM Overview
             12.5.3 Endo International PLC: Company Snapshot
             12.5.4 Product Portfolio
             12.5.5 Recent Developments (2014-2015)
     12.6 Boston Scientific Corporation 
             12.6.1 Company Overview
             12.6.2 MnM Overview
             12.6.3 Product Portfolio
             12.6.4 Recent Developments (2014-2015)
     12.7 Neuwave Medical, Inc.
             12.7.1 Company Overview
             12.7.3 Edap Tms S.A.: Company Snapshot
             12.7.4 Product Portfolio
             12.7.5 Recent Developments (2014-2015)
     12.8 Edap Tms S.A.
             12.8.1 Company Overview
             12.8.2 Product Portfolio
             12.8.3 Recent Developments (2014-2015)
     12.9 Mermaid Medical A/S 
             12.9.1 Company Overview
             12.9.2 Product Portfolio
             12.9.3 Recent Developments (2014-2015)
     12.10 Sonacare Medical, LLC 
             12.10.1 Company Overview
             12.10.2 Misonix, Inc.: Company Snapshot
             12.10.3 Product Portfolio
             12.10.4 Recent Developments (2014-2015)
     12.11 Misonix, Inc.
             12.11.1 Company Overview
             12.11.2 Product Portfolio
             12.11.3 Recent Developments (2014-2015)

13 Appendix
     13.1 Insights From Industry Experts
     13.2 Discussion Guide
     13.3 Introducing RT: Real Time Market Intelligence
     13.4 Available Customizations
     13.5 Related Reports


List of Tables (72 Tables)

Table 1 Global Tumor Ablation Market Size, By Technology, 2014-2021 (USD Million)
Table 2 Market Size for Radiofrequency Ablation Technologies, By Region, 2014-2021 (USD Million)
Table 3 Market Size for Microwave Ablation Technology, By Region, 2014-2021 (USD Million)
Table 4 Market Size for Cryoablation Technology, By Region, 2014-2021 (USD Million)
Table 5 Market Size for Other Technologies, By Region, 2014-2021 (USD Million)
Table 6 Global Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 7 Market Size for Surgical Ablation Treatment, By Region, 2014-2021 (USD Million)
Table 8 Market Size for Laparoscopic Ablation Treatment, By Region, 2014-2021 (USD Million)
Table 9 Market Size for Percutaneous Ablation Treatment, By Region, 2014-2021 (USD Million)
Table 10 Tumor Ablation Market Size, By Application, 2014-2021 (USD Million)
Table 11 Market Size for Liver Cancer Ablation, By Region, 2014-2021 (USD Million)
Table 12 Market Size for Lung Cancer Ablation, By Region, 2014-2021 (USD Million)
Table 13 Market Size for Kidney Cancer Ablation, By Region, 2014-2021 (USD Million)
Table 14 Market Size for Bone Metastasis Ablation, By Region, 2014-2021 (USD Million)
Table 15 Market Size for Other Applications, By Region, 2014-2021 (USD Million)
Table 16 Market Size, By Region, 2014-2021 (USD Million)
Table 17 North American Market Size, By Country, 2014-2021 (USD Million)
Table 18 North American Market Size, By Technology, 2014-2021 (USD Million)
Table 19 North American Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 20 North American Market Size, By Application, 2014-2021 (USD Million)
Table 21 U.S.: Tumor Ablation Market Size, By Technology, 2014-2021 (USD Million)
Table 22 U.S.: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 23 U.S.: Market Size, By Application, 2014-2021 (USD Million)
Table 24 Canada: Tumor Ablation Market Size, By Technology, 2014-2021 (USD Million)
Table 25 Canada: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 26 Canada: Market Size, By Application, 2014-2021 (USD Million)
Table 27 European Market Size, By Country, 2014-2021 (USD Million)
Table 28 European Market Size, By Technology, 2014-2021 (USD Million)
Table 29 European Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 30 European Market Size, By Application, 2014-2021 (USD Million)
Table 31 Italy: Tumor Ablation Market Size, By Technology, 2014-2021 (USD Million)
Table 32 Italy: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 33 Italy: Market Size, By Application, 2014-2021 (USD Million)
Table 34 Germany: Market Size, By Technology, 2014-2021 (USD Million)
Table 35 Germany: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 36 Germany: Market Size, By Application, 2014-2021 (USD Million)
Table 37 France: Tumor Ablation Market Size, By Technology, 2014-2021 (USD Million)
Table 38 France: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 39 France: Market Size, By Application, 2014-2021 (USD Million)
Table 40 U.K.: Market Size, By Technology, 2014-2021 (USD Million)
Table 41 U.K.: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 42 U.K.: Market Size, By Application, 2014-2021 (USD Million)
Table 43 Spain: Tumor Ablation Market Size, By Technology, 2014-2021 (USD Million)
Table 44 Spain: Market Size, By Mode of Treatment, 2014-2021 (USD Million
Table 45 Spain: Market Size, By Application, 2014-2021 (USD Million)
Table 46 Rest of Europe: Market Size, By Technology, 2014-2021 (USD Million)
Table 47 Rest of Europe: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 48 Rest of Europe: Market Size, By Application, 2014-2021 (USD Million)
Table 49 Asia-Pacific Market Size, By Country, 2014-2021 (USD Million)
Table 50 Asia-Pacific Market Size, By Technology, 2014-2021 (USD Million)
Table 51 Asia-Pacific Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 52 Asia-Pacific Market Size, By Application, 2014-2021 (USD Million)
Table 53 Japan: Market Size, By Technology, 2014-2021 (USD Million)
Table 54 Japan: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 55 Japan: Market Size, By Application, 2014-2021 (USD Million)
Table 56 China: Market Size, By Technology, 2014-2021 (USD Million)
Table 57 China: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 58 China: Market Size, By Application, 2014-2021 (USD Million)
Table 59 India: Tumor Ablation Market Size, By Technology, 2014-2021 (USD Million)
Table 60 India: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 61 India: Market Size, By Application, 2014-2021 (USD Million)
Table 62 Rest of Asia-Pacific: Market Size, By Technology, 2014-2021 (USD Million)
Table 63 Rest of Asia-Pacific: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 64 Rest of Asia-Pacific: Market Size, By Application, 2014-2021 (USD Million)
Table 65 RoW: Tumor Ablation Market Size, By Technology, 2014-2021 (USD Million)
Table 66 RoW: Market Size, By Mode of Treatment, 2014-2021 (USD Million)
Table 67 RoW: Market Size, By Application, 2014-2021 (USD Million)
Table 68 Top 5 New Product Launches and Product Enhancements, 2013–2016
Table 69 Top 5 Agreements, Partnerships, and Collaborations, 2013–2016
Table 70 Top 5 Geographical Expansions, 2013–2016
Table 71 Top 5 Mergers and Acquisitions, 2013–2016
Table 72 Top 5 Other Developments, 2013–2016


List of Figures (86 Figures)

Figure 1 Research Design
Figure 2 Data Triangulation
Figure 3 North America to Hold Largest Share of  Market During the Forecast Period
Figure 4 RF Ablation to Lead the Revenue Growth of Tumor Ablation Technology Market During 2016-2021
Figure 5 Microwave Ablation Technology to Grow at Fastest CAGR During Study Period
Figure 6 North America to Dominate Surgical Tumor Ablation Treatment Market Till 2021
Figure 7 Liver Cancer to Lead Tumor Ablation Application Market During Forecast Period
Figure 8 Rise in Target Patient Population to Propel the Market Growth of Liver Cancer Ablation in APAC
Figure 9 Increasing Geriatric Population Across Key Mature and Emerging Nations
Figure 10 Worldwide Prevalence of Cancer – Expected Trend Till 2020
Figure 11 Tumor Ablation Market, By Technology: Expected Trend During 2016-2021
Figure 12 Market Share: RF Ablation Technology Market, By Region (2016)
Figure 13 Market Share: Microwave Ablation Technology Market, By Region (2016)
Figure 14 Market Share: Cryoablation Technology Market, By Region (2065)
Figure 15 Market Share: Other Ablation Technologies Market, By Region (2016)
Figure 16 Market, By Mode of Treatment: Expected Trend During 2016-2021
Figure 17 Market Share: Surgical Ablation Treatment Market, By Region (2016)
Figure 18 Market Share: Laparoscopic Ablation Treatment Market, By Region (2016)
Figure 19 Tumor Ablation Market Share: Percutaneous Ablation Treatment Market, By Region (2016)
Figure 20 Market, By Application: Expected Trend During 2016-2021
Figure 21 Market Share: Liver Cancer Ablation Market, By Region (2016)
Figure 22 Market Share: Lung Cancer Ablation Market, By Region (2016)
Figure 23 Market Share: Kidney Cancer Ablation Market, By Region (2016)
Figure 24 Market Share: Bone Metastasis Ablation Market, By Region (2016)
Figure 25 Market Share: Other Applications Market, By Region (2016)
Figure 26 Key Market Drivers for Global Market (2016-2021)
Figure 27 North America: Market, Expected Trend (2016 vs 2021)
Figure 28 North America: Market Share, By Technology, 2016
Figure 29 U.S.: Key Market Drivers for Market (2016-2021)
Figure 30 U.S.: Market Share, By Technology (2016)
Figure 31 U.S.: Tumor Ablation Market Share, By Mode of Treatment (2016)
Figure 32 U.S.: Market Share, By Application (2016)
Figure 33 Canada: Key Market Drivers for Tumor Ablation Market (2016-2021)
Figure 34 Canada: Market Share, By Technology (2016)
Figure 35 Canada: Market Share, By Mode of Treatment (2016)
Figure 36 Canada: Market Share, By Application (2016)
Figure 37 Europe: Market, Expected Trend (2016 vs 2021)
Figure 38 Eu-5: Market Share, By Technology, 2016
Figure 39 Italy: Key Market Drivers for Tumor Ablation Market (2016-2021)
Figure 40 Italy: Market Share, By Technology (2016)
Figure 41 Italy: Market Share, By Mode of Treatment (2016)
Figure 42 Italy: Market Share, By Application (2016)
Figure 43 Germany: Key Market Drivers for Tumor Ablation Market (2016-2021)
Figure 44 Germany: Market Share, By Technology (2016)
Figure 45 Germany: Market Share, By Mode of Treatment (2016)
Figure 46 Germany: Market Share, By Application (2016)
Figure 47 France: Key Market Drivers for Tumor Ablation Market (2016-2021)
Figure 48 France: Market Share, By Technology (2016)
Figure 49 France: Market Share, By Mode of Treatment (2016)
Figure 50 France: Market Share, By Application (2016)
Figure 51 U.K.: Key Market Drivers for Tumor Ablation Market (2016-2021)
Figure 52 U.K.: Market Share, By Technology (2016)
Figure 53 U.K.: Market Share, By Mode of Treatment (2016)
Figure 54 U.K.: Market Share, By Application (2016)
Figure 55 Spain: Key Market Drivers for Tumor Ablation Market (2016-2021)
Figure 56 Spain: Market Share, By Technology (2016)
Figure 57 Spain: Market Share, By Mode of Treatment (2016)
Figure 58 Spain: Market Share, By Application (2016)
Figure 59 RoE: Key Market Drivers for Tumor Ablation Market (2016-2021)
Figure 60 RoE: Market Share, By Technology (2016)
Figure 61 RoE: Market Share, By Mode of Treatment (2016)
Figure 62 RoE: Market Share, By Application (2016)
Figure 63 Asia-Pacific: Tumor Ablation Market, Expected Trend (2016 vs 2021)
Figure 64 Asia-Pacific: Market Share, By Technology, 2016
Figure 65 Japan: Key Market Drivers for Tumor Ablation Market (2016-2021)
Figure 66 Japan: Market Share, By Technology (2016)
Figure 67 Japan: Market Share, By Mode of Treatment (2016)
Figure 68 Japan: Market Share, By Application (2016)
Figure 69 China: Key Market Drivers for Tumor Ablation Market (2016-2021)
Figure 70 China: Market Share, By Technology (2016)
Figure 71 China: Market Share, By Mode of Treatment (2016)
Figure 72 China: Market Share, By Application (2016)
Figure 73 India: Key Market Drivers for Tumor Ablation Market (2016-2021)
Figure 74 India: Market Share, By Technology (2016)
Figure 75 India: Market Share, By Mode of Treatment (2016)
Figure 76 India: Market Share, By Application (2016)
Figure 77 RoAPAC: Key Market Drivers for Tumor Ablation Market (2016-2021)
Figure 78 RoAPAC: Market Share, By Technology (2016)
Figure 79 RoAPAC: Market Share, By Mode of Treatment (2016)
Figure 80 RoAPAC: Market Share, By Application (2016)
Figure 81 RoW: Tumor Ablation Market, Expected Trend (2016 vs 2021)
Figure 82 RoW: Market Share, By Technology, 2016
Figure 83 Market Share Analysis: Medtronic, PLC to Lead Tumor Ablation Market Till 2021
Figure 84 Majority of Leading Players Focused on Product Development as Key Growth Strategy to Expand Their Market Share During Study Period
Figure 85 Top 4 Players Generated More Than 3/5th of Their Tumor Ablation Revenue From Americas
Figure 86 Technological Development and Product Enhancement is the Key Strategy Pursued By Top Players to Increase Their Tumor Ablation Market Revenue


Request for detailed methodology, assumptions & how numbers were triangulated.

Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
MD 3271
Published ON
Oct, 2016
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Tumor Ablation Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved